| 新型吲哚胺2,3-二加氧酶抑制剂及其治疗人类疾病的研究 |
| |
| 引用本文： | 杨云云,李锡帅,杨青. 新型吲哚胺2,3-二加氧酶抑制剂及其治疗人类疾病的研究[J]. 上海医药, 2012, 33(9): 16-19 |
| |
| 作者姓名： | 杨云云 李锡帅 杨青 |
| |
| 作者单位： | 复旦大学,上海,200433 |
| |
| 摘 要： | 吲哚胺2,3-二加氧酶(indoleamine 2,3-dioxygenase,IDO)是催化色氨酸沿犬尿氨酸代谢途径分解的限速酶,已被证实与肿瘤、阿尔茨海默病、抑郁症和白内障等多种人类疾病的发病机制密切相关.IDO抑制剂是具有新药靶、新机制的广谱药物,应用前景非常广阔.
|
| 关 键 词： | 吲哚胺2,3-二加氧酶 吲哚胺2,3-二加氧酶抑制剂 药物发现靶标 肿瘤 阿尔茨海默病 |
Research of the new indoleamine 2, 3-dioxygenaseinhibitors and its treatment of human diseases |
| |
| YANG Yun-yun , LI Xi-shuai , YANG Qing. Research of the new indoleamine 2, 3-dioxygenaseinhibitors and its treatment of human diseases[J]. Shanghai Medical & Pharmaceutical Journal, 2012, 33(9): 16-19 |
| |
| Authors: | YANG Yun-yun LI Xi-shuai YANG Qing |
| |
| Affiliation: | ***(School of Life Sciences,Fudan University,Shanghai,200433) |
| |
| Abstract: | Indoleamine 2,3-dioxygenase(IDO) is a monomeric 45 kDa heme-containing dioxygenase that catalyzes the initial and rate limiting step of L-tryptophan(L-Trp) catabolism along the kynurenine pathway(KP).IDO has been confirmed to have the close relationship of the pathogenesis mechanism with cancer,Alzheimer’s disease,depression,age-related cataract as well as other diseases characterized by pathological tryptophan metabolism.It is a broad-spectrum agent with the new molecular target and mechanism,which has the promising application prospects. |
| |
| Keywords: | indoleamine 2,3-dioxygenase inhibitor drug discovery target tumor Alzheimer’s disease |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
